Allterum Therapeutics
Houston
About Allterum Therapeutics
Allterum Therapeutics is a biopharmaceutical company that develops treatments for relapsed acute lymphoblastic leukemia and other IL-7R expressing cancers. The company is also exploring relapsed/refractory solid tumors with IL-7R over-expression. The 4A10 antibody was developed at the National Cancer Institutes (NCI) and licensed exclusively to Fannin Innovation Studio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.7M
- Funding stage: Seed
- Last round: Grant (Sep 2025)
- Website: allterum.com
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/allterum-therapeutics-113951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.